Halozyme Therapeutics, Inc. (HALO)

HALOZYME THERAPEUTICS, INC.
TickerHALOBörseNasdaq
ISINUS40637H1095CIK0001159036
69,50
Schluss · 12.06.2026
1T−1,7 %1W−2,8 %1M−0,8 %3M+9,2 %6M+11,7 %1J+27,4 %
GCS 66 → +0,0
TSI 12,4 · 12,0 ▲ 04.06.
8-K 5.02 09.12.25· 189T
Insider ▼ 03.06.26· 13T
PDF

Glück Conviction Score™

HALO HALOZYME THERAPEUTICS, INC.
Conviction Score
66
Stark
Timing / Risiko Ruhig· 60
🟢 Conviction × Timing — fundamental hohe Conviction trifft auf ein positiv drehendes Timing (Momentum/FTD). Der günstige Quadrant des Modells.
Effektiv: Stark Hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
56,3
99 neu, 249 erhöht, -1351769K $ netto
Aktivist
13,2
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

70
Technical-Score: 70 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 41.7 % — 5 bullisch / 1 bärisch / 6 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bullisch10 %67.43+3.1 % vs SMA50
Kurs vs SMA200Bullisch15 %69.24+0.4 % vs SMA200
SMA-CrossBärisch10 %DEATHvor 36 Tagen @ 68.40
EMA20 vs EMA50Bullisch5 %69.24EMA50: 68.20
MACD-HistogrammBullisch10 %0.065Bullisch
RSI(14)Neutral10 %52.4Neutral (30–70)
Stoch %K(14)Neutral5 %58.3Neutral
ADX(14)+DINeutral10 %20.3+DI: 19.8 / −DI: 14.6
Z-Score(60)Neutral5 %1.02In Range
52W-PositionNeutral5 %59.8 %Hoch 81.23 / Tief 52.02
Bollinger(20,2σ)Neutral5 %56.7 %Upper 72.24 / Mid 69.08 / Lower 65.91
LinReg-Slope(60)Bullisch10 %+0.1168R²=0.55 / annualisiert +44.1 %

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-06-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-6.10069,69-425.121,20-96,4%
2026-06-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.00068,74-137.472,00-31,2%
2026-06-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-1.50067,68-101.512,50-23,0%
2026-06-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-40066,37-26.547,20-6,0%
2026-06-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-3.40066,75-226.933,00-51,5%
2026-06-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-16.60066,31-1.100.812,40-249,7%
2026-06-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-1.61066,39-106.884,68-24,2%
2026-06-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-12.98967,41-875.588,49-198,6%
2026-06-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-5.40168,35-369.136,75-83,7%
2026-06-01Connaughton BernadetteDirectorOpen Market Sale-1.62566,21-107.591,25-24,4%
2026-05-13Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.10068,10-143.014,20-32,4%
2026-05-13Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-3.95069,79-275.658,65-62,5%
2026-05-13Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-3.35068,88-230.748,00-52,3%
2026-05-13Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-60070,81-42.487,20-9,6%
2026-05-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-1.39870,29-98.261,23-22,3%
2026-05-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-9.80271,37-699.568,74-158,7%
2026-05-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-5.90072,15-425.673,20-96,6%
2026-05-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.80073,12-204.738,80-46,4%
2026-05-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10067,85-6.785,00-1,5%
2026-05-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-6.70066,33-444.390,90-100,8%
2026-05-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-9.72564,63-628.536,48-142,6%
2026-05-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-3.57565,46-234.012,35-53,1%
2026-05-01Connaughton BernadetteDirectorOpen Market Sale-1.62563,48-103.155,00-23,4%
2026-04-06Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.10064,02-262.461,50-59,5%
2026-04-06Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-5.90063,14-372.520,10-84,5%
2026-04-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-15.80064,06-1.012.195,40-229,6%
2026-04-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.20064,89-272.525,40-61,8%
2026-04-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-1.00065,71-65.714,00-14,9%
2026-04-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-19.00065,36-1.241.802,00-281,7%
2026-03-10Caudill CortneyOfficer, SVP, CHIEF OPERATING OFFICEROpen Market Sale-8.85767,64-599.087,48-135,9%
2026-03-09Caudill CortneyOfficer, SVP, CHIEF OPERATING OFFICEROpen Market Sale-17.90067,75-1.212.742,90-275,1%
2026-03-09Caudill CortneyOfficer, SVP, CHIEF OPERATING OFFICEROpen Market Sale-2.10068,25-143.329,20-32,5%
2026-03-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-7.32969,94-512.619,58-116,3%
2026-03-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.67170,95-189.494,10-43,0%
2026-03-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-13.48168,85-928.166,85-210,5%
2026-03-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-6.51969,33-451.981,83-102,5%
2026-03-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.10069,20-283.707,70-64,4%
2026-03-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-15.32269,80-1.069.460,28-242,6%
2026-03-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-57870,46-40.726,46-9,2%
2026-02-05Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-5.37678,38-421.365,50-95,6%
2026-02-05Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.62478,94-365.000,06-82,8%
2026-02-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10.10077,54-783.154,00-177,6%
2026-02-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-9.90076,94-761.666,40-172,8%
2026-02-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.55174,88-191.016,33-43,3%
2026-02-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-9.65975,94-733.543,10-166,4%
2026-02-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-7.79076,73-597.757,86-135,6%
2026-01-05Connaughton BernadetteDirectorOpen Market Sale-2.00070,25-140.500,00-31,9%
2025-12-01Connaughton BernadetteDirectorOpen Market Sale-82971,60-59.356,40-13,5%
2025-12-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-26171,60-18.687,60-4,2%
2025-12-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-50070,36-35.181,00-8,0%
2025-12-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-5.40269,44-375.120,28-85,1%
2025-12-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10.40668,51-712.935,87-161,7%
2025-11-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-6.78471,09-482.267,78-109,4%
2025-11-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-49871,67-35.690,17-8,1%
2025-11-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-12.71870,22-893.032,52-202,6%
2025-11-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.00068,80-275.180,00-62,4%
2025-11-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-11.50069,73-801.906,50-181,9%
2025-11-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.50067,89-305.514,00-69,3%
2025-11-10Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10069,30-6.930,00-1,6%
2025-11-10Connaughton BernadetteDirectorOpen Market Sale-2.00068,48-136.960,00-31,1%
2025-11-10Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-19.90068,71-1.367.408,60-310,2%
2025-11-01Caudill CortneyOfficer, SVP, CHIEF OPERATING OFFICEROpen Market Sale-4.26365,19-277.904,97-63,0%
2025-10-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.33469,83-162.983,22-37,0%
2025-10-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-14.23568,47-974.698,92-221,1%
2025-10-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.70770,58-191.065,47-43,3%
2025-10-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-72471,67-51.890,53-11,8%
2025-10-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-70073,24-51.265,20-11,6%
2025-10-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10.20071,28-727.035,60-164,9%
2025-10-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-6.60070,51-465.359,40-105,6%
2025-10-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.40072,07-172.956,00-39,2%
2025-10-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10074,67-7.466,50-1,7%
2025-10-01Connaughton BernadetteDirectorOpen Market Sale-1.50075,09-112.629,00-25,5%
2025-10-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-11.70575,11-879.150,85-199,4%
2025-10-01Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-8.29575,69-627.873,44-142,4%
2025-10-01Connaughton BernadetteDirectorOpen Market Sale-50075,70-37.852,00-8,6%
2025-09-22LaBrosse NicoleOfficer, SVP, CHIEF FINANCIAL OFFICEROpen Market Sale-1.91377,83-148.883,05-33,8%
2025-09-22LaBrosse NicoleOfficer, SVP, CHIEF FINANCIAL OFFICEROpen Market Sale-31478,67-24.701,44-5,6%
2025-09-10LaBrosse NicoleOfficer, SVP, CHIEF FINANCIAL OFFICEROpen Market Sale-6.76075,29-508.967,16-115,4%
2025-09-10LaBrosse NicoleOfficer, SVP, CHIEF FINANCIAL OFFICEROpen Market Sale-13.24075,93-1.005.299,96-228,0%
2025-09-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-9.90073,54-728.006,40-165,1%
2025-09-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-7.80074,33-579.750,60-131,5%
2025-09-04Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-2.30075,22-173.015,20-39,2%
2025-09-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-10.50074,63-783.636,00-177,8%
2025-09-03Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-9.50074,22-705.090,00-159,9%
2025-09-02Connaughton BernadetteDirectorOpen Market Sale-10071,71-7.171,00-1,6%
2025-09-02Connaughton BernadetteDirectorOpen Market Sale-92374,11-68.404,45-15,5%
2025-09-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-16.28873,70-1.200.393,02-272,3%
2025-09-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-3.41274,15-252.989,56-57,4%
2025-09-02Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-30072,49-21.745,50-4,9%
2025-09-02Connaughton BernadetteDirectorOpen Market Sale-2.97773,62-219.160,79-49,7%
2025-08-13Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-14.94864,15-958.839,46-217,5%
2025-08-13Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-5.05264,83-327.511,06-74,3%
2025-08-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-13.04263,24-824.802,16-187,1%
2025-08-12Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-6.95864,00-445.318,96-101,0%
2025-08-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-18.71763,01-1.179.320,74-267,5%
2025-08-11Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-1.28363,60-81.596,23-18,5%
2025-07-10Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-15.74657,62-907.237,28-205,8%
2025-07-10Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.25456,74-241.380,47-54,8%
2025-07-09Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-19.79256,43-1.116.783,39-253,3%
2025-07-09Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-20857,08-11.871,81-2,7%
2025-07-08Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-3.59854,48-196.029,83-44,5%
2025-07-08Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-16.40255,74-914.214,68-207,4%
2025-06-24Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-4.48953,11-238.406,30-54,1%
2025-06-24Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-15.51153,91-836.213,52-189,7%
2025-06-23Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-20.00052,57-1.051.460,00-238,5%
2025-06-20Torley HelenDirector, Officer, PRESIDENT AND CEOOpen Market Sale-20.00052,96-1.059.200,00-240,3%

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
BlackRock, Inc.20.890.05318.903.8571.986.196867.076.530Aufgestockt+10,5%
VANGUARD GROUP INC11.566.896011.566.896778.452.101Neu+100,0%
VANGUARD CAPITAL MANAGEMENT LLC5.271.21805.271.218340.678.819Neu+100,0%
STATE STREET CORP13.975.85414.759.672-783.818330.786.146Reduziert-5,3%
Invesco Ltd.10.512.4948.148.0632.364.431267.644.237Aufgestockt+29,0%
BANK OF AMERICA CORP /DE/5.026.1096.917.832-1.891.723190.977.806Reduziert-27,3%
Boston Partners2.683.683487.0692.196.614173.432.991Aufgestockt+451,0%
MORGAN STANLEY4.977.30912.433.299-7.455.990168.688.554Reduziert-60,0%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2.525.9751.842.956683.019163.253.764Aufgestockt+37,1%
GEODE CAPITAL MANAGEMENT, LLC2.505.7862.433.19372.593161.982.673Aufgestockt+3,0%
SNYDER CAPITAL MANAGEMENT L P2.323.0772.399.188-76.111150.140.467Reduziert-3,2%
DIMENSIONAL FUND ADVISORS LP2.079.8272.104.157-24.330134.398.148Reduziert-1,2%
NORGES BANK1.904.92201.904.922128.201.251Neu+100,0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.918.1493.222.507-1.304.358123.969.970Reduziert-40,5%
D. E. Shaw & Co., Inc.1.899.4081.649.466249.942122.758.740Aufgestockt+15,2%
ALLIANCEBERNSTEIN L.P.1.736.5011.835.486-98.985116.866.517Reduziert-5,4%
WELLS FARGO & COMPANY/MN9.092.73712.547.517-3.454.780108.634.839Reduziert-27,5%
ROYAL LONDON ASSET MANAGEMENT LTD1.610.5531.371.271239.282104.090.040Aufgestockt+17,4%
JUPITER ASSET MANAGEMENT LTD1.608.2561.569.55938.697103.941.586Aufgestockt+2,5%
TWO SIGMA INVESTMENTS, LP1.584.961717.369867.592102.436.029Aufgestockt+120,9%
FIRST TRUST ADVISORS LP1.482.3401.011.782470.55895.803.603Aufgestockt+46,5%
FULLER & THALER ASSET MANAGEMENT, INC.1.465.2831.379.57585.70894.701.251Aufgestockt+6,2%
MIZUHO MARKETS AMERICAS LLC1.323.5441.268.67354.87185.540.649Aufgestockt+4,3%
FRANKLIN RESOURCES INC9.528.0399.309.678218.36185.510.936Aufgestockt+2,3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.289.5331.241.82947.70483.342.518Aufgestockt+3,8%
CONGRESS ASSET MANAGEMENT CO1.280.5921.302.180-21.58882.764.661Reduziert-1,7%
JANUS HENDERSON GROUP PLC1.233.658863.956369.70279.741.989Aufgestockt+42,8%
Stephens Investment Management Group LLC1.218.6681.223.665-4.99778.762.513Reduziert-0,4%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.1.186.9511.518.405-331.45476.713.000Reduziert-21,8%
BANK OF MONTREAL /CAN/7.689.5976.784.267905.33076.612.235Aufgestockt+13,3%
TD ASSET MANAGEMENT INC1.168.666931.704236.96275.530.884Aufgestockt+25,4%
Epoch Investment Partners, Inc.1.138.377533.359605.01873.573.306Aufgestockt+113,4%
FEDERATED HERMES, INC.1.123.2661.574.621-451.35572.596.682Reduziert-28,7%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC1.121.2001.224.009-102.80972.463.156Reduziert-8,4%
NORTHERN TRUST CORP1.111.2311.096.30714.92471.818.860Aufgestockt+1,4%
TENOR CAPITAL MANAGEMENT Co., L.P.55.026.00039.626.00015.400.00071.004.180Aufgestockt+38,9%
CITADEL ADVISORS LLC44.828.85165.884.900-21.056.04970.746.121Reduziert-32,0%
Point72 Asset Management, L.P.54.851.00048.351.0006.500.00068.677.931Aufgestockt+13,4%
MILLENNIUM MANAGEMENT LLC29.394.28421.436.9487.957.33667.606.022Aufgestockt+37,1%
AQR CAPITAL MANAGEMENT LLC1.016.4291.158.359-141.93064.817.665Reduziert-12,3%
Pacer Advisors, Inc.937.2930937.29363.079.819Neu+100,0%
JPMORGAN CHASE & CO28.903.537028.903.53762.487.438Neu+100,0%
UBS Group AG979.3331.366.973-387.64059.140.076Reduziert-28,4%
Capital World Investors3.026.9023.034.874-7.97259.113.736Reduziert-0,3%
LMR Partners LLP45.000.00040.508.0004.492.00057.712.500Aufgestockt+11,1%
JANE STREET GROUP, LLC1.004.407226.644777.76357.441.107Aufgestockt+343,2%
Nuveen, LLC12.932.12412.984.891-52.76751.064.011Reduziert-0,4%
JACOBS LEVY EQUITY MANAGEMENT, INC789.429876.957-87.52851.020.796Reduziert-10,0%
GOLDMAN SACHS GROUP INC1.630.1401.358.139272.00148.345.683Aufgestockt+20,0%
Gotham Asset Management, LLC746.841439.708307.13348.268.334Aufgestockt+69,8%

Top-Fondshalter (Stand: 31.03.2026)

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
BlackRock, Inc.20.890.05318.903.857+10,5%867.076.53011,20
VANGUARD CAPITAL MANAGEMENT LLC5.271.2180+100,0%340.678.8194,40
STATE STREET CORP13.975.85414.759.672-5,3%330.786.1464,27
Invesco Ltd.10.512.4948.148.063+29,0%267.644.2373,46
BANK OF AMERICA CORP /DE/5.026.1096.917.832-27,3%190.977.8062,47
Boston Partners2.683.683487.069+451,0%173.432.9912,24
MORGAN STANLEY4.977.30912.433.299-60,0%168.688.5542,18
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC2.525.9751.842.956+37,1%163.253.7642,11
GEODE CAPITAL MANAGEMENT, LLC2.505.7862.433.193+3,0%161.982.6732,09
SNYDER CAPITAL MANAGEMENT L P2.323.0772.399.188-3,2%150.140.4671,94
DIMENSIONAL FUND ADVISORS LP2.079.8272.104.157-1,2%134.398.1481,74
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.918.1493.222.507-40,5%123.969.9701,60
D. E. Shaw & Co., Inc.1.899.4081.649.466+15,2%122.758.7401,59
ALLIANCEBERNSTEIN L.P.1.736.5011.835.486-5,4%116.866.5171,51
WELLS FARGO & COMPANY/MN9.092.73712.547.517-27,5%108.634.8391,40
ROYAL LONDON ASSET MANAGEMENT LTD1.610.5531.371.271+17,4%104.090.0401,34
JUPITER ASSET MANAGEMENT LTD1.608.2561.569.559+2,5%103.941.5861,34
TWO SIGMA INVESTMENTS, LP1.584.961717.369+120,9%102.436.0291,32
FIRST TRUST ADVISORS LP1.482.3401.011.782+46,5%95.803.6031,24
FULLER & THALER ASSET MANAGEMENT, INC.1.465.2831.379.575+6,2%94.701.2511,22

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.2026657795,18.624
31.12.20256471.139,89.582
30.09.20256521.694,110.713
30.06.20256001.555,17.389
31.03.20255861.750,59.813
31.12.20245411.753,57.398

Top 10 Neueinsteiger

FondsAnteileWert (USD) ⓘ
NORGES BANK1.904.922128.201.251
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1.842.956124.030.939
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.1.518.405102.189.000
Lombard Odier Asset Management (Europe) Ltd15.493.00020.575.943
SILVERBACK ASSET MANAGEMENT LLC9.819.00010.629.068
GLENMEDE TRUST CO NA119.8668.066.981
LGT Fund Management Co Ltd.88.0005.957.600
Pinnacle Financial Partners, Inc.84.0375.655.690
Assenagon Asset Management S.A.72.0854.851.321
Verity Asset Management, Inc.53.1183.574.841

Top 10 Aufstocker

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
CITADEL ADVISORS LLC65.884.90051.549.499+359.6 %79.513.851
Point72 Asset Management, L.P.48.351.00014.405.000+42.4 %62.361.850
Focus Partners Wealth6.199.8996.076.806+4936.8 %15.455.060
ANGELO GORDON & CO., L.P.10.000.0005.000.000+100.0 %10.775.000
Jain Global LLC25.000.0005.000.000+25.0 %33.228.250
CITIGROUP INC5.510.1033.838.212+229.6 %39.445.595
Warberg Asset Management LLC8.000.0002.858.000+55.6 %10.630.367
PIER 88 INVESTMENT PARTNERS LLC2.530.2802.439.220+2678.7 %4.003.502
SSI INVESTMENT MANAGEMENT LLC7.398.0001.243.000+20.2 %9.492.797
MIZUHO MARKETS AMERICAS LLC1.268.673926.526+270.8 %85.381.693

Top 10 Verkäufer

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
MILLENNIUM MANAGEMENT LLC21.436.948-127.418.636-85.6 %128.346.295
LINDEN ADVISORS LP12.993.000-67.930.000-83.9 %17.261.965
Calamos Advisors LLC17.548.000-51.687.000-74.7 %26.850.557
MACKAY SHIELDS LLC5.239.000-45.264.000-89.6 %5.645.263
BlackRock, Inc.18.903.857-41.831.342-68.9 %892.884.859
LAZARD ASSET MANAGEMENT LLC18.422.243-37.058.755-66.8 %3.487.589
STATE STREET CORP14.759.672-21.324.535-59.1 %357.469.177
BALYASNY ASSET MANAGEMENT L.P.14.785.000-20.293.000-57.9 %19.653.922
TENOR CAPITAL MANAGEMENT Co., L.P.39.626.000-15.620.000-28.3 %52.784.405
Universal- Beteiligungs- und Servicegesellschaft mbH3.535.149-13.505.310-79.3 %17.871.861

Zusätzlich aktuell von 56 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →

Aktivisten & Großaktionäre (13D/13G)

DatumInvestorTypAnteilAktienΔZweck
30.04.2026Vanguard Capital ManagementPassiv (13G)5,21 %6.173.547Neu
27.03.2026The Vanguard GroupPassiv (13G/A)Ausstieg0-10,04 pp
17.07.2025BlackRock, Inc.Passiv (13G/A)10,20 %12.612.300-2,90 pp
13.05.2025STATE STREET CORPORATIONPassiv (13G)4,90 %6.053.007-0,30 pp
28.04.2025BlackRock, Inc.Passiv (13G/A)13,10 %16.144.164Neu
12.11.2024 Artisan Partners Asset Management Inc.Passiv (13G/A)2,50 %3.133.412-2,60 pp
12.11.2024 Artisan Partners Limited PartnershipPassiv (13G/A)2,50 %3.133.412-2,60 pp
12.11.2024 Artisan Investments GP LLCPassiv (13G/A)2,50 %3.133.412-2,60 pp
12.11.2024 Artisan Partners Holdings LPPassiv (13G/A)2,50 %3.133.412-2,60 pp
17.10.2024STATE STREET CORPORATIONPassiv (13G)5,20 %6.635.827Neu
13.02.2024The Vanguard GroupPassiv (13G/A)10,04 %13.259.514-0,23 pp
12.02.2024 Artisan Investments GP LLCPassiv (13G/A)5,10 %6.689.058Neu
12.02.2024 Artisan Partners Asset Management Inc.Passiv (13G/A)5,10 %6.689.058Neu
12.02.2024 Artisan Partners Holdings LPPassiv (13G/A)5,10 %6.689.058Neu
12.02.2024 Artisan Partners Limited PartnershipPassiv (13G/A)5,10 %6.689.058Neu
01.02.2024Invesco Ltd.Passiv (13G/A)2,10 %2.816.427-3,10 pp
23.01.2024. BlackRock, Inc.Passiv (13G/A)14,10 %18.629.818-0,10 pp
09.06.2023The Vanguard GroupPassiv (13G/A)10,27 %13.528.630+0,43 pp
10.02.2023. BlackRock, Inc.Passiv (13G/A)14,20 %19.196.061+0,60 pp
10.02.2023Artisan Partners Limited PartnershipPassiv (13G/A)5,30 %7.140.953-1,50 pp
10.02.2023Artisan Partners Holdings LPPassiv (13G/A)5,30 %7.140.953-1,50 pp
10.02.2023Artisan Partners Asset Management Inc.Passiv (13G/A)5,30 %7.140.953-1,50 pp
10.02.2023Artisan Investments GP LLCPassiv (13G/A)5,30 %7.140.953-1,50 pp
10.02.2023Invesco Ltd.Passiv (13G)5,20 %7.036.951Neu
09.02.2023The Vanguard GroupPassiv (13G/A)9,84 %13.303.847-0,18 pp
26.01.2023. BlackRock, Inc.Passiv (13G/A)13,60 %18.214.0710,00 pp
20.01.2023. BlackRock, Inc.Passiv (13G)13,60 %18.214.071-0,20 pp
12.12.2022The Vanguard GroupPassiv (13G/A)10,02 %13.542.589+0,43 pp
10.02.2022The Vanguard GroupPassiv (13G/A)9,59 %13.495.913-0,14 pp
04.02.2022Artisan Investments GP LLCPassiv (13G/A)6,80 %9.505.768-0,80 pp
04.02.2022Artisan Partners Holdings LPPassiv (13G/A)6,80 %9.505.768-0,80 pp
04.02.2022Artisan Partners Limited PartnershipPassiv (13G/A)6,80 %9.505.768-0,80 pp
04.02.2022Artisan Partners Asset Management Inc.Passiv (13G/A)6,80 %9.505.768-0,80 pp
28.01.2022. BlackRock, Inc.Passiv (13G/A)13,80 %19.439.863+0,10 pp

US Congress Trades (STOCK Act)

DatumMitgliedParteiKammerTypBetrag-Bereich
09.03.2026Gilbert CisnerosHouseKauf$1,001 – $15,000

Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →

Stammdaten

Halozyme Therapeutics, Inc. ist ein Biopharma-Technologieplattformunternehmen in den Vereinigten Staaten, der Schweiz, Irland, Belgien, Japan und international. Die Produkte des Unternehmens basieren auf der ENHANZE-Arzneimittelabgabetechnologie, einem patentierten rekombinanten menschlichen Hyaluronidase-Enzym (rHuPH20), das die subkutane Verabreichung biologischer Injektionsmittel wie monoklonaler Antikörper und anderer therapeutischer Moleküle sowie kleinmolekularer Substanzen und Flüssigkeiten ermöglicht. Das Flaggschiff-Produkt ist Hylenex recombinant, eine Formulierung von rHuPH20 zur Erleichterung der subkutanen Flüssigkeitsverabreichung für die Hydratation, um die Ausbreitung und Absorption anderer injizierter Arzneimittel in der subkutanen Urographie zu verbessern und die Resorption von radioopaken Mitteln zu verbessern. Das Unternehmen entwickelt auch Perjeta; RITUXAN HYCELA und MabThera SC zur Behandlung von Non-Hodgkin-Lymphom und chronisch lymphatischer Leukämie (CLL); RITUXAN SC für Patienten mit CLL; und HYQVIA zur Behandlung von Immunmangelstörungen. Darüber hinaus entwickelt es Tecentriq für Nicht-kleinzelliges Lungenkarzinom; OCREVUS für Multiple Sklerose; DARZALEX zur Behandlung von Patienten mit Amyloidose, schwelender Myelom und Multiplem Myelom; Nivolumab zur Behandlung solider Tumoren; ARGX-113, einen menschlichen neonatalen Fc-Rezeptor; ARGX-117 zur Behandlung von Autoimmunerkrankungen; und BMS-986179, einen Anti-CD-73-Antikörper. Das Unternehmen kooperiert mit F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; und ViiV Healthcare Limited an klein- und großmolekularen Zielen zur Behandlung und Prävention von HIV. Halozyme Therapeutics, Inc. wurde 1998 gegründet und hat seinen Sitz in San Diego, Kalifornien.

Unternehmen & Branche

NameHALOZYME THERAPEUTICS, INC.
TickerHALO
CIK0001159036
BoerseNasdaq
SektorHealthcare
IndustrieBiotechnology
SIC2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP40637H109
ISINUS40637H1095
TypCommon Stock
Marktkapitalisierung8,19 Mrd. USD
KGV (P/E)27,15
Beta0,87

Bewertung

KBV (P/B)167,69 vs. 28,07 (2021)
KUV (P/S)5,86 vs. 12,47 (2021)
EV/EBITDA21,2 vs. 22,5 (2021)
FCF-Rendite7,9 % vs. 5,4 % (2021)
Buyback-Rendite4,2 % vs. 6,3 % (2021)

Qualität & Bilanz

Bruttomarge83,6 % vs. 81,6 % (2021)
Operative Marge33,6 % vs. 62,2 % (2021)
Nettomarge22,7 % vs. 90,8 % (2021)
ROIC14,5 % vs. 37,5 % (2021)
Nettoverschuldung/EBITDA4,2 vs. 2,7 (2021)
Zinsdeckungsgrad25,9 vs. 36,7 (2021)

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025Verlauf
Bewertung
KBV (P/B)28,0745,2955,9116,18162,39
KUV (P/S)12,4711,655,655,805,68
EV/EBITDA22,532,717,413,020,7
FCF-Rendite5,4 %3,1 %8,0 %8,0 %8,1 %
Buyback-Rendite6,3 %2,6 %8,6 %4,2 %4,3 %
Qualität & Bilanz
Bruttomarge81,6 %78,9 %76,8 %84,3 %83,6 %
Operative Marge62,2 %40,5 %40,7 %54,3 %33,6 %
Nettomarge90,8 %30,6 %34,0 %43,7 %22,7 %
ROIC37,5 %12,1 %17,8 %23,8 %14,5 %
Nettoverschuldung/EBITDA2,74,64,02,54,2
Zinsdeckungsgrad36,715,818,030,525,9

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q376.708.000150.049.0001,222.672.719.000219.636.000
2025-12-3110-K1.396.611.000316.889.0002,562.525.323.00048.814.000
2025-09-3010-Q354.264.000175.225.0001,432.221.232.000503.915.000
2025-06-3010-Q325.719.000165.160.0001,332.053.899.000332.748.000
2025-03-3110-Q264.861.000118.095.0000,932.196.532.000482.270.000
2024-12-3110-K1.015.324.000444.091.0003,432.063.477.000363.821.000
2024-09-3010-Q290.084.000137.011.0001,052.118.030.000452.703.000
2024-06-3010-Q231.353.00093.245.0000,721.969.453.000289.424.000
2024-03-3110-Q195.879.00076.823.0000,601.841.527.000177.808.000
2023-12-3110-K829.253.000281.594.0002,101.733.270.00083.808.000
2023-09-3010-Q216.033.00081.837.0000,611.892.662.000249.181.000
2023-06-3010-Q221.038.00074.754.0000,561.810.440.000151.033.000
2023-03-3110-Q162.143.00039.615.0000,291.699.447.00065.850.000
2022-12-3110-K660.116.000202.129.0001,441.841.511.000169.798.000
2022-09-3010-Q208.976.00061.634.0000,441.864.543.00096.991.000
2022-06-3010-Q152.365.00022.685.0000,161.781.390.000293.171.000
2022-03-3110-Q117.279.00060.108.0000,431.162.248.000260.256.000
2021-12-3110-K443.310.000402.710.0002,741.104.429.000196.953.000
2021-09-3010-Q115.830.000216.587.0001,481.185.420.000281.674.000
2021-06-3010-Q136.455.00091.458.0000,621.025.863.000119.746.000

Umsatz nach Segmenten & Regionen

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
Royalty867,8 Mio.571,0 Mio.447,9 Mio.360,5 Mio.203,9 Mio.45,1 %+52,0%
Product376,4 Mio.303,5 Mio.300,9 Mio.191,0 Mio.104,2 Mio.19,6 %+24,0%
Proprietary Products Sales194,6 Mio.166,6 Mio.130,8 Mio.72,8 Mio.10,1 %+16,8%
Collaborative Agreements152,3 Mio.140,8 Mio.80,5 Mio.108,6 Mio.135,2 Mio.7,9 %+8,2%
Bulk RHu PH 20133,0 Mio.86,3 Mio.115,4 Mio.82,1 Mio.6,9 %+54,1%
Salesbasedmilestone70,0 Mio.30,0 Mio.10,0 Mio.50,0 Mio.3,6 %+133,3%
Device Partnered Products48,8 Mio.50,5 Mio.54,6 Mio.36,1 Mio.2,5 %-3,4%
Event Based Development And Regulatory Milestone And Other Fees47,0 Mio.72,5 Mio.69,0 Mio.59,0 Mio.2,4 %-35,2%
Upfront Fees18,5 Mio.27,0 Mio.2,0 Mio.30,0 Mio.1,0 %-31,6%
Device Licensing And Development16,9 Mio.11,3 Mio.9,5 Mio.9,6 Mio.0,9 %+48,6%
Bulkr Hu PH 2081,0 Mio.
Development Fees42,0 Mio.
Upfrontfees42,0 Mio.
Hylenex Recombinant23,3 Mio.
Researchand Development Services1,2 Mio.

Quartalsergebnisse (Earnings)

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202611.05.2026376,7 Mio. USD1,22
Q3 202530.09.202503.11.2025354,3 Mio. USD1,43
Q2 202530.06.202505.08.2025325,7 Mio. USD1,33
Q1 202531.03.202511.05.2026264,9 Mio. USD0,93
Q3 202430.09.202403.11.2025290,1 Mio. USD1,05
Q2 202430.06.202405.08.2025231,4 Mio. USD0,72
Q1 202431.03.202406.05.2025195,9 Mio. USD0,60
Q3 202330.09.202331.10.2024216,0 Mio. USD0,61
Q2 202330.06.202306.08.2024221,0 Mio. USD0,56

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
11.05.2026 10-Q 31.03.2026 41 Tage SEC »
17.02.2026 10-K 31.12.2025 48 Tage SEC »
03.11.2025 10-Q 30.09.2025 34 Tage SEC »
05.08.2025 10-Q 30.06.2025 36 Tage SEC »
06.05.2025 10-Q 31.03.2025 36 Tage SEC »
18.02.2025 10-K 31.12.2024 49 Tage SEC »
31.10.2024 10-Q 30.09.2024 31 Tage SEC »
06.08.2024 10-Q 30.06.2024 37 Tage SEC »
07.05.2024 10-Q 31.03.2024 37 Tage SEC »
20.02.2024 10-K 31.12.2023 51 Tage SEC »
06.11.2023 10-Q 30.09.2023 37 Tage SEC »
08.08.2023 10-Q 30.06.2023 39 Tage SEC »
09.05.2023 10-Q 31.03.2023 39 Tage SEC »
21.02.2023 10-K 31.12.2022 52 Tage SEC »
08.11.2022 10-Q 30.09.2022 39 Tage SEC »
09.08.2022 10-Q 30.06.2022 40 Tage SEC »
10.05.2022 10-Q 31.03.2022 40 Tage SEC »
22.02.2022 10-K 31.12.2021 53 Tage SEC »
02.11.2021 10-Q 30.09.2021 33 Tage SEC »
09.08.2021 10-Q 30.06.2021 40 Tage SEC »
10.05.2021 10-Q 31.03.2021 40 Tage SEC »
23.02.2021 10-K 31.12.2020 54 Tage SEC »
02.11.2020 10-Q 30.09.2020 33 Tage SEC »
10.08.2020 10-Q 30.06.2020 41 Tage SEC »

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
09.12.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
08.12.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
24.11.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
06.10.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
21.03.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
13.02.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECSection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors…
23.02.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
06.02.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…
15.03.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
03.02.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
13.12.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
05.05.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
03.05.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
24.02.2020Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-05-261.04668,3271.463
2026-05-20668,73412
2026-05-191667,441.079
2026-05-1843767,1229.331
2026-05-1366270,9346.956
2026-05-081365,19847
2026-05-041.64663,96105.278
2026-04-298.51463,86543.704
2026-04-2895064,4961.265
2026-04-246766,594.462
2026-04-2321568,4014.706
2026-04-174566,642.999
2026-04-163668,052.450
2026-04-082.29163,60145.708
2026-04-021.22665,4080.180
2026-03-31262,13124
2026-03-272.10663,29133.289
2026-03-251662,04993
2026-03-2462862,8639.476
2026-03-202263,271.392
2026-03-185265,133.387
2026-03-1327.13063,561.724.383
2026-03-125966,483.922
2026-03-0913.16667,37886.993
2026-02-2614770,3510.341
2026-02-1948973,2335.809
2026-02-115.61180,22450.114
2026-02-099781,237.879
2026-02-05277,93156
2026-02-0427.39276,482.094.940
2026-02-033.11174,45231.614
2026-01-287.77270,22545.750
2026-01-2710.38069,87725.251
2026-01-2610.29469,22712.551
2026-01-148.67071,67621.379
2026-01-1329672,4221.436
2026-01-089275,116.910
2026-01-053370,312.320
2025-12-3157.66067,703.903.582
2025-12-3055268,9538.060
2025-12-23268,16136
2025-12-2278567,3552.870
2025-12-1830.99465,772.038.475
2025-12-171264,47774

Hinweis

Erweitert ×